70 related articles for article (PubMed ID: 10388104)
1. Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.
Borden EC
Oncologist; 1998; 3(3):198-203. PubMed ID: 10388104
[TBL] [Abstract][Full Text] [Related]
2. [Interferons, a class of cytokines with a large therapeutic activity range].
Billard C
Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
[TBL] [Abstract][Full Text] [Related]
3. The role of interferons in the treatment of malignant neoplasms.
Murren JR; Buzaid AC
Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
[TBL] [Abstract][Full Text] [Related]
5. New Advances in Interferon Therapy of Cancer.
Wadler S; Schwartz EL
Oncologist; 1997; 2(4):254-267. PubMed ID: 10388057
[TBL] [Abstract][Full Text] [Related]
6. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
O'Malley BW; Li D; McQuone SJ; Ralston R
Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
[TBL] [Abstract][Full Text] [Related]
7. [Cytokines in children with immunodeficiencies].
Kowalczyk D
Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
[TBL] [Abstract][Full Text] [Related]
8. [Interferon--a new therapeutic principle].
Micksche M
Wien Med Wochenschr; 1993; 143(16-17):408-12. PubMed ID: 8273362
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic role of beta-interferons in multiple sclerosis.
Javed A; Reder AT
Pharmacol Ther; 2006 Apr; 110(1):35-56. PubMed ID: 16229894
[TBL] [Abstract][Full Text] [Related]
10. Second-generation interferons for cancer: clinical targets.
Borden EC; Lindner D; Dreicer R; Hussein M; Peereboom D
Semin Cancer Biol; 2000 Apr; 10(2):125-44. PubMed ID: 10936063
[TBL] [Abstract][Full Text] [Related]
11. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
12. Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer.
Makower D; Wadler S
Semin Oncol; 1999 Dec; 26(6):663-71. PubMed ID: 10606259
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the antitumor effects of interferon-alpha and beta on human hepatocellular carcinoma cell lines.
Murata M; Nabeshima S; Kikuchi K; Yamaji K; Furusyo N; Hayashi J
Cytokine; 2006 Feb; 33(3):121-8. PubMed ID: 16522372
[TBL] [Abstract][Full Text] [Related]
15. Antitumor vaccination: where we stand.
Bocchia M; Bronte V; Colombo MP; De Vincentiis A; Di Nicola M; Forni G; Lanata L; Lemoli RM; Massaia M; Rondelli D; Zanon P; Tura S
Haematologica; 2000 Nov; 85(11):1172-206. PubMed ID: 11074658
[TBL] [Abstract][Full Text] [Related]
16. Strategies for the development of more effective adjuvant therapy of melanoma: current and future explorations of antibodies, cytokines, vaccines, and combinations.
Kirkwood JM; Moschos S; Wang W
Clin Cancer Res; 2006 Apr; 12(7 Pt 2):2331s-2336s. PubMed ID: 16609054
[TBL] [Abstract][Full Text] [Related]
17. The genes of interferons and interferon-related factors: localization and relationships with chromosome aberrations in cancer.
Haus O
Arch Immunol Ther Exp (Warsz); 2000; 48(2):95-100. PubMed ID: 10807049
[TBL] [Abstract][Full Text] [Related]
18. Principles in the biomodulation of cytotoxic drugs by interferons.
Wadler S; Schwartz EL
Semin Oncol; 1992 Apr; 19(2 Suppl 3):45-8. PubMed ID: 1373005
[TBL] [Abstract][Full Text] [Related]
19. The interferons. Mechanisms of action and clinical applications.
Baron S; Tyring SK; Fleischmann WR; Coppenhaver DH; Niesel DW; Klimpel GR; Stanton GJ; Hughes TK
JAMA; 1991 Sep; 266(10):1375-83. PubMed ID: 1715409
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems.
Bocci V
Crit Rev Ther Drug Carrier Syst; 1992; 9(2):91-133. PubMed ID: 1378776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
